Despite reports from Merck and Johnson & Johnson, pharma's net prices 'likely not coming down': analyst
fiercepharma | April 10, 2018
Are drug prices coming down? Two leading drugmakers presented numbers suggesting the industry is facing increased pricing pressure, but Bernstein analyst Ronny Gal remains skeptical. Johnson & Johnson recently reported that net prices fell 4.6% in 2017 after the company paid out $15 billion in rebates and discounts. Merck said its net prices fell 1.9% last year. Of J&J's disclosure, Gal wrote on Monday that he believes the situation "does not represent 'real' pressure on the industry, but rather specific company circumstances."